Master Molecular Oncology (MOM)


Program Description

Introduction and Goals

The Molecular Oncology Master – M.O.M., is a training program for clinical oncologists, pathologists, hematologists and other medical specialists or biomedical graduated students from fields associated with tumor disease. The M.O.M. is a unique initiative in the world, with more than 100 exceptional professors carefully selected at national and international level. Among M.O.M.’s faculty are the higher exponents of molecular oncology discoveries and the authors of the content they teach. The M.O.M. program is offered by the Centro de Estudios Biosanitarios (CEB) (Biosciences Studies Centre) in collaboration with the CNIO and has the recommendation of the European School of Oncology (ESO). It also has the scientific support of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Hematology and Hemotherapy (SEHH).

The M.O.M. provides training in Molecular Oncology based on a multidisciplinary approach to tumor disease, which has a positive effect in care intervention. The student will have access to basic knowledge about the origin and development of cancers, the methodology of basic research and clinical oncology, known patterns of phenotypic expression of tumors as well as other therapeutic approaches based on molecular pathways involved in carcinogenesis. With this program, you will receive a cutting-edge training for oncology specialists in the twenty-first century. Nowadays, a clinical practice of excellence cannot be conceived without a profound knowledge of the molecular basis of the disease and without a proper diagnosis, prognosis, and treatment based on each patient molecular markers.

Why do a Master in Molecular Oncology?

  • Advanced Training

The training received by specialists linked to the oncological disease during the Bachelor of Medicine and subsequent specialization does not delve deeper and in detail on the knowledge of the molecular basis of cancer. Today, a clinical practice of excellence cannot be conceived without the knowledge of the molecular basis of the disease.

  • Leading Clinical Practice

Diagnosis, prognosis, and treatment based on the molecular pattern of the patient allow cutting-edge clinical practice. New therapeutic strategies are based on specific molecular targets inhibitors, or in blocking or activating certain routes. It is imperative a specialized training that allows professionals to deepen in the molecular basis of cancer and at the same time patients benefit from this knowledge.

  • Advanced in Research

Oncology from XXIst century is based on the progress of the investigation. Only a joint translational research effort can bring these advances to patients. Research and training are essential tools to address cancer in daily clinical practice. Both approaches are needed for a correct patient treatment.


Credits: 120 ECTS


  • Module I Cellular and Molecular Biology of Cancer
  • Module II Molecular Pathology
  • Module III Molecular Oncology
  • Module IV Research Project

Lab Internships

Students may take a lab internship in small groups at CNIO accessing to the latest technologies for diagnosis, prognosis, and monitoring of tumor disease.

Final research work

The student will carry out a research project supervised by one of the directors of M.O.M.


The M.O.M. is taught online. The student will access to recorded classes through the CEB e-learning platform. Teacher’s power point presentation will be available to students for download. Students can send queries to teachers from the e-learning platform.


12 months Starting date: September 19th, 2016


Molecular Oncology Master Private and not official degree awarded by the Centro de Estudios Biosanitarios. Modules accredited by the competent authority. Credits valid for public offering employment.


The faculty includes internationally recognized researchers and oncologists from institutions such Hasrvard-Beth Israel Deaconess Medical Center, Centro Nacional de Investigaciones Oncológicas (CNIO), MD Anderson Cancer Center, CSIC, Vall d’Hebron Institut de Recerca, among other.


Module I: Cellular and Molecular Biology of Cancer

(September 2016 – December 2016)

This module will cover the basic knowledge of cell biology and mechanisms flag of gene regulation, and changes caused by malignant transformation. Molecular Processes will be reviewed, including genes controlling cell proliferation and biological activity of the main proto-oncogenes and tumor suppressor genes and the Implications of tampering. Also study the importance of the repair of genetic damage and mutator route in carcinogenesis, the basis of the processes of apoptosis, cellular senescence and immortalization, stem cells, angiogenesis and lymphangiogenesis and tumor immunology.

Main subjects:

  • 1. Cell, genes, and regulation of gene expression.
  • 2. Proto-oncogenes and oncogenes.
  • 3. Tumor suppressors genes.
  • 4. Cellular Processes involved in Carcinogenesis.

Module II: Molecular Pathology

(January 2017 – March 2017)

Understanding through didactic presentations and optional laboratory work, basic aspects of molecular diagnostics, the technical and conceptual basis, its implementation in clinical practice in selected diseases. After completion of the module, the student must be able to:

  • Understand the basic vocabulary and concepts of molecular diagnostics;
  • Understand the conceptual foundations of the main techniques, their limitations, and applications;
  • Interpret results of these techniques;
  • Interpret and evaluate scientific publications based on studies of molecular pathology;
  • Identify key areas of pathology where these techniques can be of practical use.

Main subjects:

  • 1. Immunohistochemistry.
  • 2. Cytogenetics.
  • 3. Cancer genome.
  • 4. Gene expression regulation and analysis. Transcriptomics. MiRNAS.
  • 5. Proteomics.
  • 6. Epigenetics.

Module III: Molecular Oncology

(April 2017 – June 2017)

This module contains aspects of epidemiology, carcinogenesis, and inheritance and analyzes the knowledge about newly updated review of the possibilities of different approaches to the design of drugs, the current state of drug search directed against molecular targets.

We will review the various forms of immune therapy and gene therapy, and discuss the clinical trial methodology and application of molecular targets in addition to diagnosis and prognosis, problems and prospects in this field.

Main subjects:

  • 1. Epidemiology and agents related to cancer risk.
  • 2. Family Cancer.
  • 3. Pharmacology and antitumoral agents.
  • 4. More treatment strategies.
  • 5. Clinical research methodology.

Module IV: Research Project

Students will perform a research project which may consist of conducting a research project developed in laboratories and/or hospitals, or in a literature review on a topic of antitumor therapies allowing interest in Molecular Oncology, or in designing a research project. During the months assigned to carry out the research project, the student will have a tutor. It is essential to have the approval of the tutor for the research work can be evaluated.

Requirements and Admission

Addressed to:

  • Specialists in Oncology
  • Specialists in Pathology
  • Specialists in Hematology
  • Specialists in Radiotherapy
  • Other Graduates or Doctors in Biosciences areas with an interest in tumor disease

Selection and Deadlines

Candidates must hold a bachelor’s degree in a biomedical area. You need to send your updated CV, in order to be evaluated by the Academic Board before for admission in the program.


Send your CV to:

Eugenia Fernández Cámara

Last updated Mar 2020

About the School

Biosanitary Studies Center (CEB) is a company dedicated to consulting work practice, management consulting and teaching projects, research and development in the field of experimental sciences and hea ... Read More

Biosanitary Studies Center (CEB) is a company dedicated to consulting work practice, management consulting and teaching projects, research and development in the field of experimental sciences and health sciences. Read less